Cargando…
Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU
BCL6B is a potential tumor suppressor in human gastric cancer, but the regulation and mechanism of BCL6B in human hepatocellular carcinogenesis remain unclear. This study is to explore the epigenetic change and mechanism of BCL6B in human hepatocellular carcinoma (HCC). Nineteen hepatic cancer cell...
Autores principales: | Li, Xin, Yu, Jie, Brock, Malcolm V., Tao, Qian, Herman, James G., Liang, Ping, Guo, Mingzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484475/ https://www.ncbi.nlm.nih.gov/pubmed/25909168 |
Ejemplares similares
-
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
por: Li, Hongxia, et al.
Publicado: (2018) -
Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling
por: Yan, Wenji, et al.
Publicado: (2014) -
Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017) -
BCL7C suppresses ovarian cancer growth by inactivating mutant p53
por: Huang, Canhua, et al.
Publicado: (2020) -
Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling
por: Yang, Weili, et al.
Publicado: (2022)